ARTICLE | Company News
Celldex, TopoTarget deal
February 22, 2010 8:00 AM UTC
Celldex received a $3 million sublicense payment from TopoTarget after TopoTarget's deal earlier this month with Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI, Irvine, Calif.) to co-develop and commerci...